Literature DB >> 30608082

Adipose-derived stem cell-secreted factors promote early stage follicle development in a biomimetic matrix.

Claire E Tomaszewski1, Elizabeth Constance, Melissa M Lemke, Hong Zhou, Vasantha Padmanabhan, Kelly B Arnold, Ariella Shikanov.   

Abstract

Development of primary follicles in vitro benefits from a three-dimensional matrix that is enriched with paracrine factors secreted from feeder cells and mimics the in vivo environment. In this study, we investigated the role of paracrine signaling from adipose-derived stem cells (ADSCs) in supporting primary follicle development in a biomimetic poly(ethylene glycol) (PEG)-based matrix. Follicles co-cultured with ADSCs and follicles cultured in conditioned medium from ADSCs encapsulated in gels (3D CM) exhibited significantly (p < 0.01 and p = 0.09, respectively) improved survival compared to follicles cultured in conditioned medium collected from ADSCs cultured in flasks (2D CM) and follicles cultured without paracrine support. The gene expression of ADSCs suggested that the stem cells maintained their multipotency in the 3D PEG environment over the culture period, regardless of the presence of the follicles, while under 2D conditions the multipotency markers were downregulated. The differences in cytokine signatures of follicles exposed to 3D and 2D ADSC paracrine factors suggest that early cytokine interactions are key for follicle survival. Taken together, the biomimetic PEG scaffold provides a three-dimensional, in vivo-like environment to induce ADSCs to secrete factors which promote early stage ovarian follicle development and survival.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30608082      PMCID: PMC6351215          DOI: 10.1039/c8bm01253a

Source DB:  PubMed          Journal:  Biomater Sci        ISSN: 2047-4830            Impact factor:   6.843


  7 in total

1.  Human Ovarian Follicles Xenografted in Immunoisolating Capsules Survive Long Term Implantation in Mice.

Authors:  Margaret A Brunette; Hadrian M Kinnear; Prianka H Hashim; Colleen L Flanagan; James R Day; Marilia Cascalho; Vasantha Padmanabhan; Ariella Shikanov
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-03       Impact factor: 6.055

2.  Ovarian tissue cryopreservation and novel bioengineering approaches for fertility preservation.

Authors:  Andrea S K Jones; Ariella Shikanov
Journal:  Curr Breast Cancer Rep       Date:  2020-11-04

3.  Sequestered cell-secreted extracellular matrix proteins improve murine folliculogenesis and oocyte maturation for fertility preservation.

Authors:  Claire E Tomaszewski; Katarina M DiLillo; Brendon M Baker; Kelly B Arnold; Ariella Shikanov
Journal:  Acta Biomater       Date:  2021-03-22       Impact factor: 10.633

4.  Adaptive Gelatin Microspheres Enhanced Stem Cell Delivery and Integration With Diabetic Wounds to Activate Skin Tissue Regeneration.

Authors:  Ming Shi; Yunfen Gao; Lim Lee; Ting Song; Jianhua Zhou; Ling Yan; Yan Li
Journal:  Front Bioeng Biotechnol       Date:  2022-04-01

5.  Adipose-derived stem cells promote survival, growth, and maturation of early-stage murine follicles.

Authors:  Lisa J Green; Hong Zhou; Vasantha Padmanabhan; Ariella Shikanov
Journal:  Stem Cell Res Ther       Date:  2019-03-21       Impact factor: 6.832

6.  Human amnion-derived mesenchymal stem cells improved the reproductive function of age-related diminished ovarian reserve in mice through Ampk/FoxO3a signaling pathway.

Authors:  Hanwen Liu; Chunyan Jiang; Boya La; Meng Cao; Song Ning; Jing Zhou; Zhengjie Yan; Chuyu Li; Yugui Cui; Xiang Ma; Meilian Wang; Li Chen; Youjia Yu; Feng Chen; Yuexin Zhang; Huimin Wu; Jiayin Liu; Lianju Qin
Journal:  Stem Cell Res Ther       Date:  2021-06-02       Impact factor: 6.832

7.  Capitalizing on transcriptome profiling to optimize and identify targets for promoting early murine folliculogenesis in vitro.

Authors:  Andrea Jones; Beatriz Peñalver Bernabé; Vasantha Padmanabhan; Jun Li; Ariella Shikanov
Journal:  Sci Rep       Date:  2021-06-15       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.